Free Trial
LON:NFX

Nuformix (NFX) Share Price, News & Analysis

Nuformix logo
GBX 0.08 0.00 (-2.50%)
As of 06:11 AM Eastern

About Nuformix Stock (LON:NFX)

Key Stats

Today's Range
0.08
0.08
50-Day Range
0.08
0.16
52-Week Range
0.04
0.30
Volume
672,722 shs
Average Volume
53.88 million shs
Market Capitalization
£960.81 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 293
Consensus Rating
Buy

Company Overview

Nuformix Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
30th Percentile Overall Score

NFX MarketRank™: 

Nuformix scored higher than 30% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nuformix has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Nuformix has received no research coverage in the past 90 days.

  • Read more about Nuformix's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nuformix is -2.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nuformix is -2.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Nuformix has a P/B Ratio of 0.14. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Short Interest

    There is no current short interest data available for NFX.
  • Dividend Yield

    Nuformix does not currently pay a dividend.

  • Dividend Growth

    Nuformix does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for NFX.
  • Search Interest

    5 people have searched for NFX on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nuformix insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    12.44% of the stock of Nuformix is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 0.12% of the stock of Nuformix is held by institutions.

  • Read more about Nuformix's insider trading history.
Receive NFX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nuformix and its competitors with MarketBeat's FREE daily newsletter.

NFX Stock News Headlines

Trump’s biggest move, misreported
The media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada the 51st state because he’s desperate for critical minerals… They think his involvement in Ukraine is just another resource grab… They think his tariffs will wreck the economy… But they’re all missing the bigger picture.
See More Headlines

NFX Stock Analysis - Frequently Asked Questions

Nuformix's stock was trading at GBX 0.05 at the start of the year. Since then, NFX shares have increased by 73.3% and is now trading at GBX 0.08.

Nuformix plc (LON:NFX) issued its quarterly earnings data on Friday, May, 2nd. The company reported $0.03 EPS for the quarter.

Shares of NFX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nuformix investors own include Allena Pharmaceuticals (ALNA), Rolls-Royce Holdings plc (RR), UK Oil & Gas (UKOG), 88 Energy (88E), Ampliphi Biosciences (APHB), Argo Blockchain (ARB) and Ardelyx (ARDX).

Company Calendar

Last Earnings
5/02/2025
Today
8/04/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:NFX
Previous Symbol
LON:LVRT
CIK
N/A
Fax
N/A
Employees
3
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 293
Low Price Target
GBX 293
Potential Upside/Downside
+375,541.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX (0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£383.40 thousand
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-5.68%
Return on Assets
-17.20%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.12
Quick Ratio
3.35

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
GBX 0.02 per share
Price / Cash Flow
3.55
Book Value
GBX 0.54 per share
Price / Book
0.14

Miscellaneous

Outstanding Shares
1,231,809,091
Free Float
N/A
Market Cap
£960.81 thousand
Optionable
Not Optionable
Beta
1.22
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (LON:NFX) was last updated on 8/4/2025 by MarketBeat.com Staff
From Our Partners